Search
Angeliq (drospirenone, estradiol)
Trademark: Angeliq
Indications:
- treatment of menopausal symptoms
Adverse effects:
- drospirenone may increase of venous thromboembolism [2]
Mechanism of action:
- combination progestin/estrogen Manufacturers: Berlex
Interactions
drug adverse effects of estrogens
General
drospirenone/estradiol
References
- Prescriber's Letter 13(2): 2006
Detail-Document#: 220215
(subscription needed) http://www.prescribersletter.com
- FDA Safety Alert: Posted 05/31/2011
Birth Control Pills Containing Drospirenone: Possible
Increased Risk of Blood Clots
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm257337.htm
Components
17-beta estradiol (E2, Estrace, Estinyl, Delestrogen, Elestrin, Evamist, Imvexxy)
drospirenone